Titre:
  • Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers.
Auteur:Awada, Ahmad; Gil, Thierry; Sales, Francois; Dubuisson, Michel Raymond; Vereecken, P; Klastersky, Jean; Moerman, Carine; De Valeriola, Dominique; Piccart-Gebhart, Martine
Informations sur la publication:Anti-cancer drugs, 15, 5, page (499-502)
Statut de publication:Publié, 2004-06
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Dacarbazine -- administration & dosage
Dacarbazine -- analogs & derivatives
Doxorubicin -- administration & dosage
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Liposomes
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms -- drug therapy
Neutropenia -- chemically induced
Stomatitis -- chemically induced
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase I
Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0959-4973
info:pii/00001813-200406000-00012
info:pmid/15166625